Concord Acquisition Corp II Files 8-K on Financials
Ticker: CNDAW · Form: 8-K · Filed: May 20, 2024 · CIK: 1851959
| Field | Detail |
|---|---|
| Company | Concord Acquisition CORP II (CNDAW) |
| Form Type | 8-K |
| Filed Date | May 20, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, spac
Related Tickers: CNDA
TL;DR
CNDA filed an 8-K detailing its common stock and warrant terms, with warrants exercisable at $11.50.
AI Summary
Concord Acquisition Corp II filed an 8-K on May 20, 2024, reporting on its financial statements and exhibits. The filing pertains to its common stock and warrants, with a par value of $0.0001 per share for the common stock and an exercise price of $11.50 for the warrants. The company is incorporated in Delaware and its principal executive offices are located at 477 Madison Avenue, New York, NY.
Why It Matters
This filing provides an update on the financial structure and details of Concord Acquisition Corp II, including its stock and warrant terms, which is important for investors tracking the company's status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and exhibits, not indicating any immediate operational or financial distress.
Key Numbers
- 0.0001 — Par Value per Share (Class Common Stock)
- 11.50 — Warrant Exercise Price (Per whole warrant)
Key Players & Entities
- Concord Acquisition Corp II (company) — Registrant
- May 20, 2024 (date) — Date of earliest event reported
- 477 Madison Avenue, New York, NY (location) — Principal executive offices
- 0.0001 (dollar_amount) — Par value per share of Class Common Stock
- 11.50 (dollar_amount) — Exercise price for warrants
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on financial statements and exhibits of Concord Acquisition Corp II.
What is the par value of Concord Acquisition Corp II's Class Common Stock?
The par value of Concord Acquisition Corp II's Class Common Stock is $0.0001 per share.
What is the exercise price for Concord Acquisition Corp II's warrants?
The exercise price for Concord Acquisition Corp II's warrants is $11.50 per whole warrant.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 20, 2024.
Where are the principal executive offices of Concord Acquisition Corp II located?
The principal executive offices of Concord Acquisition Corp II are located at 477 Madison Avenue, New York, NY.
Filing Stats: 1,512 words · 6 min read · ~5 pages · Grade level 14.9 · Accepted 2024-05-20 16:00:34
Key Financial Figures
- $0.0001 — hange Class A Common Stock, par value $0.0001 per share CNDA The New York Stock E
- $11.50 — A Common Stock at an exercise price of $11.50 CNDA.WS The New York Stock Exchange
Filing Documents
- tm2414972d1_8k.htm (8-K) — 40KB
- 0001104659-24-063386.txt ( ) — 271KB
- cnda-20240520.xsd (EX-101.SCH) — 4KB
- cnda-20240520_def.xml (EX-101.DEF) — 27KB
- cnda-20240520_lab.xml (EX-101.LAB) — 39KB
- cnda-20240520_pre.xml (EX-101.PRE) — 26KB
- tm2414972d1_8k_htm.xml (XML) — 7KB
01. Regulation
Item 7.01. Regulation FD Disclosure. On May 20, 2024, Concord Acquisition Corp II (the "Company") announced that it had entered into a non - binding letter of intent for a business combination (the "Business Combination") with an industry - leading marketplace and SaaS platform in the fintech, events management, AI, and consumer engagement space (the "Target"). The completion of the proposed Business Combination is subject to, among other things, the completion of due diligence, the negotiation of definitive agreements for the Business Combination (the "Definitive Agreements"), satisfaction of the conditions negotiated therein, approval of the transaction by the board and stockholders of both the Company and Target, as well as regulatory approvals and other customary conditions. There can be no assurance that Definitive Agreements will be entered into or that the Business Combination will be consummated on the terms or timeframe currently contemplated, or at all. The information in this Item 7.01 is furnished pursuant to the rules and regulation of the Securities and Exchange Commission (the "SEC") and shall not be deemed "filed" for purposes of Section 18 of the U.S. Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the U.S. Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K (the "Report") includes forward-looking statements that involve risks and uncertainties. Forward-looking could cause actual results to differ from the forward-looking statements. These forward-looking statements and factors that may cause such differences include, without limitation, uncertainties relating to the Company's ability to enter into Definitive Agreements within the time provided in the Company's amended and restated certificate of incorporation, or at all; the performance of the Target's business; the risk that the approval of the Company's stockholders for the business combination is not obtained; failure to realize the anticipated benefits of the proposed Business Combination, including as a result of a delay in consummating the Business Combination; the amount of redemption requests made by the Company's stockholders and the amount of funds remaining in the Company's trust account after satisfaction of such requests; the Company's and the Target's ability to satisfy the conditions to closing the Business Combination; the Target's ability to enter into binding agreements for financing in connection with the proposed Business Combination; and other risks and uncertainties indicated from time to time in filings with the SEC, including the definitive proxy statement filed by the Company on May 15, 2024 (the "Definitive Proxy Statement") in connection with the special meeting of the Company's stockholders called by the Company and scheduled to be held on May 30, 2024 and the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, in each case under the heading "Risk Factors," and other documents the Company has filed, or will file, with the SEC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which s
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CONCORD ACQUISITION CORP II By: /s/ Jeff Tuder Name: Jeff Tuder Title: Chief Executive Officer Date: May 20, 2024